Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Trinity Biotech (TRIB) over the last 14 years, with Q2 2025 value amounting to 0.85.

  • Trinity Biotech's Debt Ratio rose 1935.33% to 0.85 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.85, marking a year-over-year increase of 1935.33%. This contributed to the annual value of 0.72 for FY2024, which is 485.83% up from last year.
  • Latest data reveals that Trinity Biotech reported Debt Ratio of 0.85 as of Q2 2025, which was up 1935.33% from 0.72 recorded in Q4 2024.
  • Over the past 5 years, Trinity Biotech's Debt Ratio peaked at 0.85 during Q2 2025, and registered a low of 0.43 during Q2 2022.
  • Moreover, its 4-year median value for Debt Ratio was 0.65 (2024), whereas its average is 0.62.
  • Over the last 5 years, Trinity Biotech's Debt Ratio had its largest YoY gain of 4214.22% in 2023, and its largest YoY loss of 2489.79% in 2023.
  • Quarter analysis of 4 years shows Trinity Biotech's Debt Ratio stood at 0.48 in 2022, then surged by 42.14% to 0.68 in 2023, then rose by 4.86% to 0.72 in 2024, then rose by 18.66% to 0.85 in 2025.
  • Its last three reported values are 0.85 in Q2 2025, 0.72 for Q4 2024, and 0.68 during Q3 2024.